About Reverse Medical
Reverse Medical is a Healthcare company based in Irvine (United States) founded in 2007 by Michael M Henson and Jeffrey Valko, and was acquired by Covidien in August 2014. Endovascular devices for stroke and vascular diseases are manufactured. Reverse Medical has raised $15.5 million across 2 funding rounds from investors including Covidien, Early Stage Partners and Emergent Medical Partners. The company was acqui-hired. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include CoAxia, Sequent Medical and Metactive Medical; 3 of its 3 listed competitors have raised funding.
Company details
Reverse Medical, a medical device company, is focused on developing products for the endovascular management of acute stroke, neurovascular diseases and peripheral vascular disease. Reverse manufactures vessel occlusion devices for closing blood vessels during embolization. Embolization is a minimally invasive procedure is used to stop bleeding and restrict blood flow to cancerous tumors or uterine fibroids. The self-expanding MVP Micro Vascular Plug System targets the peripheral vasculature, while the UNO Neurovascular Embolization System is for intracranial use. It also sells the ReVerse Microcatheter delivery device and Barrel Vascular Reconstruction Device for treating for treating intracranial aneurysms (a bulge in a blood vessel in the brain). All the products have CE marks, and the MVP has a 510(k) clearance from the FDA, according to the release. In addition, in 2013 the company entered into an agreement with Century Medical to distribute its products in Japan. In 2014, Reverse Medical was acquired by Covidien for an undisclosed amount.
- Headquarters Irvine, United States
- Founders Michael M Henson, Jeffrey Valko
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website reversemed.com
- Acquired by Covidien (Aug 2014)
Funding Insights of Reverse Medical
Reverse Medical has successfully raised a total of $15.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $14 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.5M
- Total Rounds 2
- Last Round Series B — $14M
- First Round $1.5M
(Jun 2009)
- Investors Count 6
All 2 funding rounds of Reverse Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2010 | $14M | Series B | – | Early Stage Partners, Emergent Medical Partners | – |
| Jun 2009 | $1.5M | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Reverse Medical
Reverse Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Covidien, Early Stage Partners and Emergent Medical Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments in US tech companies are made. | 2001 | esplp.com | Cleveland, United States | |
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
Wexford Capital is engaged in alternative investment solutions. | 1994 | wexford.com | West Palm Beach, United States | |
Stage Capital is focused on private equity investments. | stagecap.com | London, United Kingdom | ||
| biostar.capital | ||||
| medfocusfunds.com | ||||
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for Reverse Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Reverse Medical
2 people are tracked at Reverse Medical (2 in leadership).
| Name | Role | Group |
|---|---|---|
Michael M Henson | Co-Founder | Leadership |
Jeffrey Valko | Co-Founder | Leadership |
Complete people profiles for Reverse Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Reverse Medical
4 dated milestones of Reverse Medical across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Reverse Medical is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series B, of $14.0M.
- Exit Acquired by Covidien.
Competitors of Reverse Medical
Reverse Medical has 3 listed competitors in our database, 3 of them funded. They include CoAxia, Sequent Medical and Metactive Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| coaxia.com | 1999 | Maple Grove, United States | $72.6M | Catheter-based treatment for cerebral ischemia | ||
| sequentmedical.com | 2007 | Aliso Viejo, United States | $65.26M | 1,028 | Catheter-based neurovascular devices for aneurysm treatment are developed. | |
| metactivemedical.com | 2011 | Olathe, United States | $4.7M | 31 | Endovascular devices are developed for peripheral and neurovascular disease treatments. |
Detailed competitors of Reverse Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Reverse Medical
Websites that share an audience with Reverse Medical (reversemed.com).
Websites whose visitors overlap most with Reverse Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Neurology
3 companies that operate in the same segment as Reverse Medical (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Reverse Medical
Reverse Medical was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Reverse Medical is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Reverse Medical is a funded company, having raised a total of $15.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jun 2009.
Reverse Medical, a medical device company, is focused on developing products for the endovascular management of acute stroke, neurovascular diseases and peripheral vascular disease. Reverse manufactures vessel occlusion devices for closing blood vessels during embolization. Embolization is a minimally invasive procedure is used to stop bleeding and restrict blood flow to cancerous tumors or uterine fibroids. The self-expanding MVP Micro Vascular Plug System targets the peripheral vasculature, while the UNO Neurovascular Embolization System is for intracranial use. It also sells the ReVerse Microcatheter delivery device and Barrel Vascular Reconstruction Device for treating for treating intracranial aneurysms (a bulge in a blood vessel in the brain). All the products have CE marks, and the MVP has a 510(k) clearance from the FDA, according to the release. In addition, in 2013 the company entered into an agreement with Century Medical to distribute its products in Japan. In 2014, Reverse Medical was acquired by Covidien for an undisclosed amount.
Reverse Medical's top competitors include Sequent Medical, Metactive Medical and CoAxia.
Reverse Medical has 7 investors. Key investors include Covidien, Early Stage Partners, Emergent Medical Partners, Wexford, and MedFocus.
Yes. Reverse Medical was acquired by Covidien in August 2014.